Internal Medicine, Gastroenterology · Stony Brook, NY
NPI
1912325044
Since 2014
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
101 Nicolls Rd # T17-066
Stony Brook, NY, 11794
Phone (631) 444-2119
Groups this clinician bills Medicare through
Medicare paid, 2024
$81K
633 services
Medicare patients, 2024
404
Average age 72
Drug cost, 2024
$295K
621 prescriptions
Company payments, 2025
$162
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Daniel S Jamorabo was code 99214 (office e&m - established), 195 times for 155 patients. In total Daniel S Jamorabo billed 633 services in 33 codes, and Medicare paid $81K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-04-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 195 | 155 | $110.83 | $22K |
| 99204 Office E&M - New | Office | 85 | 85 | $139.24 | $12K |
| 45385 Colonoscopy - Lesion Removal | Facility | 66 | 66 | $240.81 | $16K |
| 43239 Upper GI Endoscopy | Facility | 60 | 59 | $84.54 | $5,072 |
| 99222 Hospital E&M - Initial | Facility | 54 | 53 | $121.95 | $6,585 |
| 45380 Lower GI Endoscopy - Other | Facility | 34 | 34 | $105.26 | $3,579 |
| 45378 Lower GI Endoscopy - Other | Facility | 28 | 28 | $139.01 | $3,892 |
| 43235 Upper GI Endoscopy | Facility | 27 | 27 | $98.69 | $2,665 |
| 91200 Standard X-ray | Office | 24 | 24 | $27.64 | $663 |
By year: 2022 $82K for 678 services; 2023 $73K for 586 services; 2024 $81K for 633 services.
Medicare prescription drug claims, 2024
In 2024, the drug Daniel S Jamorabo prescribed most often to Medicare patients was Pantoprazole Sodium, with 107 prescriptions and refills. In total Daniel S Jamorabo wrote 621 Medicare prescriptions that cost $295K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 107 | 254 | 43 | $1,005 |
| Omeprazole Generic | 90 | 211 | 32 | $1,161 |
| Furosemide Generic | 49 | 89 | 11 | $186 |
| Linzess Linaclotide | 45 | 77 | 15 | $40K |
| Dicyclomine Hcl Generic | 38 | 68 | Under 11 | $1,327 |
| Spironolactone Generic | 35 | 63 | 12 | $558 |
| Famotidine Generic | 30 | 89 | 14 | $402 |
| Ursodiol Generic | 22 | 53 | Under 11 | $4,099 |
| Lubiprostone Generic | 19 | 29 | Under 11 | $3,155 |
| Dexlansoprazole Dr Dexlansoprazole | 17 | 31 | Under 11 | $4,657 |
| Xifaxan Rifaximin | 16 | 30 | Under 11 | $91K |
| Ondansetron Hcl Generic | 15 | 19 | Under 11 | $108 |
| Baraclude Entecavir | 13 | 13 | Under 11 | $37K |
| Rezdiffra Resmetirom | 11 | 11 | Under 11 | $44K |
Brand drugs: 146 claims; generic drugs: 475 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Daniel S Jamorabo $162 ($162 in general payments such as food, travel and fees) from 2 companies. The largest payer was Abbvie Inc. with $143.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.